Sedana Medical AB (OSTO:SEDANA)
kr 26.75 -1.05 (-3.78%) Market Cap: 2.66 Bil Enterprise Value: 2.30 Bil PE Ratio: 0 PB Ratio: 2.68 GF Score: 63/100

Q2 2021 Sedana Medical AB (publ) Earnings Call Transcript

Aug 19, 2021 / 11:30AM GMT
Release Date Price: kr82.45 (-3.90%)
Operator

Hello, and welcome to the Sedana Medical Q2 Report 2021. (Operator Instructions)

Today, I'm pleased to present acting CEO, Jens Lindberg. Please begin your meeting.

Jens Lindberg;publ;Acting CEO;VP of Commercial Operations
Sedana Medical AB

()-&

Thank you. And hi, and welcome, everyone. So for today's report, I will be joined by our CFO, Susanne Andersson; and our Chief Medical Officer, Peter Sackey.

So with that, let's get on with it, and we can move to the next slide, please, which is our disclaimer slide, which I guess we can move through relatively quickly. It's impossible to -- move the slides, please. There we go. And then the disclaimer slide, we can move to the next one as well, and I'll start with the quarterly highlights.

So this year, so if we look at Q2 and we look back, a couple of things. Clearly, first and foremost, quite happy about the approval of Sedaconda. We received the DCP approval in sort of July and then subsequently, the first national approval in France.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot